Filana Therapeutics, Inc.
FLNA
$1.42
-$0.01-0.70%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -77.90M | -90.97M | -106.03M | -123.17M | -72.79M |
| Total Depreciation and Amortization | 959.00K | 936.00K | 829.00K | 957.00K | 1.04M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 18.43M | 19.58M | 19.95M | 21.16M | -45.96M |
| Change in Net Operating Assets | 28.72M | 38.20M | 1.48M | 5.21M | 8.57M |
| Cash from Operations | -29.79M | -32.25M | -83.77M | -95.84M | -109.14M |
| Capital Expenditure | -581.00K | -581.00K | -137.00K | -74.00K | -103.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -581.00K | -581.00K | -137.00K | -74.00K | -103.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 90.00K | 1.01M | 1.01M | 102.40M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -380.00K | -329.00K | -- | -- | -- |
| Cash from Financing | -380.00K | -239.00K | 1.01M | 1.01M | 102.40M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -30.76M | -33.07M | -82.90M | -94.91M | -6.84M |